New Drug For Treating Schizophrenia Approved
Drug firm Lupin today said it has received US health regulator's approval to market generic version of Seroquel XR tablets, used in the treatment of schizophrenia, in the American market.
The company has received final approval for its Quetiapine Fumarate extended-release tablets in different strengths from the United States Food and Drug Administration (FDA), Lupin Ltd said in a statement.
The Mumbai-based company's product is generic equivalent of AstraZeneca Pharmaceuticals LP's Seroquel XR tablets which are indicated for the treatment of schizophrenia.
As per IMS MAT March sales data, Seroquel XR extended-release tablets had US sales of USD 1.27 billion. Lupin shares today ended 0.61 per cent up at Rs 1,304.90 on the BSE.
Schizophrenia is a complex mental illness in which a person loses the ability to think, feel or behave normally. The patient seems to live in a distorted world, and is usually unaware of his illness. The disorder is more commonly seen in men than women. Men tend to show the symptoms in their late teens and early twenties whereas in women, the illness is manifested later during their thirties. Nearly 6-7 million Indians suffer from this disorder, which is now believed to be a brain disorder rather than a purely psychological illness.
How is it treated Treatment approach to schizophrenia is long term and multi-pronged. It comprises not only medical intervention, but also psychological, behavioural and social rehabilitation.
(With inputs from PTI)
DoctorNDTV is the one stop site for all your health needs providing the most credible health information, health news and tips with expert advice on healthy living, diet plans, informative videos etc. You can get the most relevant and accurate info you need about health problems like diabetes, cancer, pregnancy, HIV and AIDS, weight loss and many other lifestyle diseases. We have a panel of over 350 experts who help us develop content by giving their valuable inputs and bringing to us the latest in the world of healthcare.